Ann: CYP Presents at Major International Cell Therapy Conference, page-18

Then you need to be a bit more specific. Are you suggesting Sumi' would have began some on mkt buying on the low, or would have only had talks at lower prices. The whole takeover process, were one at work (and I am not saying one is), takes time.

What you actually said was "Why would Sumitomo be back at the table after seeing mid teens? I think you guys are pumping tyres here....please don't pump rubbish".

Agree, baseless takeover pumping unhelpful. But there has been a keen buyer in market during a time most struggling micro-caps shares are getting sold down on EOFY tax selling. Its not an unreasonable proposition for other CYP holders to discuss a failed past suitor having a look at a company it tried a takeover of, that is now under new management, has significantly since advanced its trials successfully and trades at a far more modest valuation.

Not unreasonable grounds for Sumitomo to have another look. You were perhaps a bit harsh on other posters/holders.